Christopher I. Clark
Flinders University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher I. Clark.
ChemBioChem | 2003
Karl A. Hansford; Robert C. Reid; Christopher I. Clark; Joel D. A. Tyndall; Michael W. Whitehouse; Tom Guthrie; Ross P. McGeary; Karl Schafer; Jennifer L. Martin; David P. Fairlie
Few reported inhibitors of secretory phospholipase A2 enzymes truly inhibit the IIa human isoform (hnpsPLA2‐IIa) noncovalently at submicromolar concentrations. Herein, the simple chiral precursor D‐tyrosine was derivatised to give a series of potent new inhibitors of hnpsPLA2‐IIa. A 2.2‐Å crystal structure shows an inhibitor bound in the active site of the enzyme, chelated to a Ca2+ ion through carboxylate and amide oxygen atoms, H‐bonded through an amide NH group to His48, with multiple hydrophobic contacts and a T‐shaped aromatic‐group–His6 interaction. Antiinflammatory activity is also demonstrated for two compounds administered orally to rats.
Cancer Research | 2004
Roger F. Martin; Sam Broadhurst; Monica E. Reum; Christopher J. Squire; George R. Clark; Pavel N. Lobachevsky; Jonathan M. White; Christopher I. Clark; Denise Sy; M. Spotheim-Maurizot; David P. Kelly
New analogues of the minor groove binding ligand Hoechst 33342 have been investigated in an attempt to improve radioprotective activity. The synthesis, DNA binding, and in vitro radioprotective properties of methylproamine, the most potent derivative, are reported. Experiments with V79 cells have shown that methylproamine is ∼100-fold more potent than the classical aminothiol radioprotector WR1065. The crystal structures of methylproamine and proamine complexes with the dodecamer d(CGCGAATTCGCG)2 confirm that the new analogues also are minor groove binders. It is proposed that the DNA-bound methylproamine ligand acts as a reducing agent by an electron transfer mechanism, repairing transient radiation-induced oxidizing species on DNA.
Journal of Medicinal Chemistry | 2010
Giovanni Abbenante; Bernd Becker; Sébastien Blanc; Christopher I. Clark; Glenn Condie; Graeme Fraser; Matthias Grathwohl; Judy Halliday; Senka Henderson; Ann Lam; Ligong Liu; Maretta Mann; Craig Muldoon; Andrew Pearson; Rajaratnam Premraj; Tracie Ramsdale; Tony Rossetti; Karl Schafer; Giang Le Thanh; Gerald Tometzki; Frank Vari; Geraldine Verquin; Jennifer Waanders; Michael Leo West; Norbert Wimmer; Annika Yau; Johannes Zuegg; Wim Meutermans
Success in discovering bioactive peptide mimetics is often limited by the difficulties in correctly transposing known binding elements of the active peptide onto a small and metabolically more stable scaffold while maintaining bioactivity. Here we describe a scanning approach using a library of pyranose-based peptidomimetics that is structurally diverse in a systematic manner, designed to cover all possible conformations of tripeptide motifs containing two aromatic groups and one positive charge. Structural diversity was achieved by efficient selection of various chemoforms, characterized by a choice of pyranose scaffold of defined chirality and substitution pattern. A systematic scanning library of 490 compounds was thus designed, produced, and screened in vitro for activity at the somatostatin (sst(1-5)) and melanin-concentrating hormone (MCH(1)) receptors. Bioactive compounds were found for each target, with specific chemoform preferences identified in each case, which can be used to guide follow-on drug discovery projects without the need for scaffold hopping.
Journal of Organic Chemistry | 2010
Giang Le Thanh; Giovanni Abbenante; George Adamson; Bernd Becker; Christopher I. Clark; Glenn Condie; Tania Falzun; Matthias Grathwohl; Praveer Gupta; Michael Hanson; Ngoc Huynh; Peter L. Katavic; Krystle Kuipers; Ann Lam; Ligong Liu; Maretta Mann; Jeff Mason; Declan McKeveney; Craig Muldoon; Andrew Pearson; Premraj Rajaratnam; Sarah J. Ryan; Gerry Tometzki; Geraldine Verquin; Jennifer Waanders; Michael Leo West; Neil Wilcox; Norbert Wimmer; Annika Yau; Johannes Zuegg
The pyranose scaffold is unique in its ability to position pharmacophore substituents in various ways in 3D space, and unique pharmacophore scanning libraries could be envisaged that focus on scanning topography rather than diversity in the type of substituents. Approaches have been described that make use of amine and acid functionalities on the pyranose scaffolds to append substituents, and this has enabled the generation of libraries of significant structural diversity. Our general aim was to generate libraries of pyranose-based drug-like mimetics, where the substituents are held close to the scaffold, in order to obtain molecules with better defined positions for the pharmacophore substituents. Here we describe the development of a versatile synthetic route toward peptide mimetics build on 2-amino pyranose scaffolds. The method allows introduction of a wide range of substituent types, it is regio- and stereospecific, and the later diversity steps are performed on solid phase. Further, the same process was applied on glucose and allose scaffolds, in the exemplified cases, and is likely adaptable to other pyranose building blocks. The methods developed in this work give access to molecules that position the three selected binding elements in various 3D orientations on a pyranose scaffold and have been applied for the production of a systematically diverse library of several hundred monosaccharide-based mimetics.
Tetrahedron Letters | 1994
William Adcock; Christopher I. Clark; Neil A. Trout
Abstract An electrostatic rather than a hyperconjugative effect appears to be the dominant factor governing the control of Π-facial selectivity in the capture of 5-substituted(X)-2-adamantyl radicals.
Journal of the American Chemical Society | 1994
William Adcock; Christopher I. Clark; Abdelaziz Houmam; Alexander R. Krstic; Jean Pinson; Jean-Michel Savéant; Dennis K. Taylor; Julian F. Taylor
Journal of the American Chemical Society | 1996
William Adcock; Christopher I. Clark; Carl H. Schiesser
Archive | 2003
Michael Leo West; Peter R. Andrews; Tracie Elizabeth Ramsdale; Wim Meutermans; Giang Thanh Le; Christopher I. Clark; Giovanni Abbenante; Ligong Liu
Journal of Organic Chemistry | 1996
Vee Yee Chan; Christopher I. Clark; Josy Giordano; Alison J. Green; Andrew Karalis; Jonathan M. White
Archive | 2001
Robert C. Reid; Christopher I. Clark; Karl A. Hansford; Martin J. Stoermer; Ross P. McGeary; David P. Fairlie; Karl Schafer